[quote]buckeye girl wrote:
Soccerstr078 wrote:
Are you also against Gardasil which prevents cervical cancer? 12,000 females are diagnosed every year and 4,000 die from cervical cancer. We should probably go against everything that scientists do to prolong life.
Gardasil is said to protect against 4 HPV strains that are associated with cervical cancer. There are 12 other high risk strains, and over 100 HPV strains total, that the vaccine doesn’t necessarily protect against. Gardasil is not a cervical cancer vaccine, it is an HPV vaccine that could reduce the risk of cervical cancer because of the link between HPV and cancer.
I’m all for getting vaccinated against things like MMR, but at $350-400 for the Gardasil shots, no studies on the long term safety of the drug, and people pushing to make it a required vaccine for young women, you have to wonder whose best interest is in mind and who is benefiting from this drug. [/quote]
I am a fence sitter when it comes to vaccination. I believe that some are warranted (DPT) and others are either not (chickenpox), or at the very least, not well studied at this time in order to recommend to the masses (Gardasil). I have also suffered what myself and my GP believed to be a fairly severe neurological reaction to the Hep B vaccine so my opinion of vaccines in general may have been colored by my experience.
But I just wanted to share a report that I came across the other day, I hope you find it as disturbing as I did. It certainly speaks to the point that buckeyegirl made…
Novartis Says It Won’t Give Poor Free H1N1 Vaccines
LONDON (Reuters) Jun 15 - Swiss drugs company Novartis will not give free vaccines against H1N1 flu to poor countries, though it will consider discounts, the Financial Times reported on Sunday.
“If you want to make production sustainable, you have to create financial incentives,” the FT quoted Novartis Chief Executive Daniel Vasella as saying in an early edition of Monday’s paper.
The director-general of the World Health Organisation, Margaret Chan, has called for drugs companies to show solidarity with poor countries as they develop vaccines against the pandemic H1N1 virus, commonly known as swine flu.
As well as Novartis, U.S. company Baxter International and Europe’s Sanofi-Aventis, GlaxoSmithKline and Solvay are working on vaccines.
H1N1 has infected around 30,000 people globally, mostly in North America, though there have been few deaths outside Mexico and the United States. Europe suffered its first death on Sunday after a patient with pre-existing health problems died in Scotland.